News

Lithium Americas is developing Thacker Pass, the largest lithium-clay deposit in the U.S., with $2.26B in secured funding and ...
Medically reviewed by Femi Aremu, PharmD Zoloft (sertraline) can help manage mental health conditions like depression and anxiety disorders, but it can be involved in drug-drug interactions. These ...
Alzamend Neuro developed a head coil for high-resolution brain imaging in Phase 2 trials, aiming to optimize lithium dosing for neurological conditions.
Delta Lithium Limited is optimistic about the future of the lithium market despite recent challenges, as it strengthens its financial position and expands lithium and gold resources. The company ...
Lithium Medication Information Discover comprehensive details about Lithium, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
ATLANTA - Alzamend Neuro, Inc. (NASDAQ: ALZN), a biopharmaceutical company engaged in developing treatments for Alzheimer's and other mental health disorders, has confirmed the successful ...
The company's AL001 treatment delivers lithium at a dose of 240 mg, taken three times daily, and is designed as a lithium-salicylate/L-proline engineered ionic cocrystal.
ATLANTA, October 16, 2024--Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s ...